JESSICA NURSICK: Open Payments
NPI 1063040525 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,201 in 148 payments from 24 companies in 2025. Trend: 2023 $1,652 · 2024 $3,225 · 2025 $3,201
Food & beverage: $3,201
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $783 |
| AstraZeneca Pharmaceuticals LP | 25 | $636 |
| Novo Nordisk Inc | 12 | $262 |
| Aimmune Therapeutics, Inc. | 8 | $240 |
| PFIZER INC. | 14 | $209 |
| GlaxoSmithKline, LLC. | 10 | $187 |
| Amgen Inc. | 5 | $124 |
| Exact Sciences Corporation | 4 | $97 |
| Phathom Pharmaceuticals, Inc. | 2 | $97 |
| Lilly USA, LLC | 4 | $97 |
Products named: VRAYLAR, BREZTRI, QULIPTA, ZENPEP, FARXIGA, JARDIANCE, TRELEGY ELLIPTA, UBRELVY.
Industry payments across CT — which companies pay providers there.
